Literature DB >> 19199479

Structural requirements for a lipoamino acid in modulating the anticonvulsant activities of systemically active galanin analogues.

Liuyin Zhang1, Charles R Robertson, Brad R Green, Timothy H Pruess, H Steve White, Grzegorz Bulaj.   

Abstract

Introduction of lipoamino acid (LAA), Lys-palmitoyl, and cationization into a series of galanin analogues yielded systemically active anticonvulsant compounds. To study the relationship between the LAA structure and anticonvulsant activity, orthogonally protected LAAs were synthesized in which the Lys side chain was coupled to fatty acids varying in length from C(8) to C(18) or was coupled to a monodispersed polyethylene glycol, PEG(4). Galanin receptor affinity, serum stability, lipophilicity (log D), and activity in the 6 Hz mouse model of epilepsy of each of the newly synthesized analogues were determined following systemic administration. The presence of various LAAs or Lys(MPEG(4)) did not affect the receptor binding properties of the modified peptides, but their anticonvulsant activities varied substantially and were generally correlated with their lipophilicity. Our results suggest that varying the length or polarity of the LAA residue adjacent to positively charged amino acid residues may effectively modulate the antiepileptic activity of the galanin analogues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19199479      PMCID: PMC2765488          DOI: 10.1021/jm801397w

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  39 in total

1.  Improved bioavailability to the brain of glycosylated Met-enkephalin analogs.

Authors:  R D Egleton; S A Mitchell; J D Huber; J Janders; D Stropova; R Polt; H I Yamamura; V J Hruby; T P Davis
Journal:  Brain Res       Date:  2000-10-20       Impact factor: 3.252

Review 2.  The role of galanin as a multi-functional neuropeptide in the nervous system.

Authors:  D Wynick; S W Thompson; S B McMahon
Journal:  Curr Opin Pharmacol       Date:  2001-02       Impact factor: 5.547

Review 3.  Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability.

Authors:  K A Witt; T J Gillespie; J D Huber; R D Egleton; T P Davis
Journal:  Peptides       Date:  2001-12       Impact factor: 3.750

4.  In vivo and in vitro effects of peripheral galanin on nociceptive transmission in naive and neuropathic states.

Authors:  S J L Flatters; A J Fox; A H Dickenson
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

5.  Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy.

Authors:  Christophe Rousselle; Philippe Clair; Maria Smirnova; Yuri Kolesnikov; Gavril W Pasternak; Stephanie Gac-Breton; Anthony R Rees; Jean-Michel Scherrmann; Jamal Temsamani
Journal:  J Pharmacol Exp Ther       Date:  2003-04-07       Impact factor: 4.030

6.  Studies on the internalization mechanism of cationic cell-penetrating peptides.

Authors:  Guillaume Drin; Sylvine Cottin; Emmanuelle Blanc; Anthony R Rees; Jamal Temsamani
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

7.  Development of novel lipid-peptide hybrid compounds with antibacterial activity from natural cationic antibacterial peptides.

Authors:  Hyun-Sik Oh; Seunghee Kim; Hyeongjin Cho; Keun-Hyeung Lee
Journal:  Bioorg Med Chem Lett       Date:  2004-03-08       Impact factor: 2.823

8.  Lipoamino acid-based adjuvant carrier system: enhanced immunogenicity of group a streptococcal peptide epitopes.

Authors:  Aniko Horvath; Colleen Olive; Allan Wong; Timothy Clair; Penny Yarwood; Michael Good; Istvan Toth
Journal:  J Med Chem       Date:  2002-03-14       Impact factor: 7.446

9.  Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities.

Authors:  Grzegorz Bulaj; Brad R Green; Hee-Kyoung Lee; Charles R Robertson; Karen White; Liuyin Zhang; Marianna Sochanska; Sean P Flynn; Erika Adkins Scholl; Timothy H Pruess; Misty D Smith; H Steve White
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

Review 10.  The participation of galanin in pain processing at the spinal level.

Authors:  Hong-Xiang Liu; Tomas Hökfelt
Journal:  Trends Pharmacol Sci       Date:  2002-10       Impact factor: 14.819

View more
  12 in total

1.  Generating orally active galanin analogues with analgesic activities.

Authors:  Charles R Robertson; Timothy H Pruess; Erin Grussendorf; H Steve White; Grzegorz Bulaj
Journal:  ChemMedChem       Date:  2012-02-28       Impact factor: 3.466

2.  Position and length of fatty acids strongly affect receptor selectivity pattern of human pancreatic polypeptide analogues.

Authors:  Veronika Mäde; Kathrin Bellmann-Sickert; Anette Kaiser; Jens Meiler; Annette G Beck-Sickinger
Journal:  ChemMedChem       Date:  2014-08-22       Impact factor: 3.466

3.  Synthesis and biological evaluation of novel pyrimidine derivatives as sub-micromolar affinity ligands of GalR2.

Authors:  Vasudeva Naidu Sagi; Tianyu Liu; Xiaoying Lu; Tamas Bartfai; Edward Roberts
Journal:  Bioorg Med Chem Lett       Date:  2011-09-25       Impact factor: 2.823

Review 4.  Glutamatergic Mechanisms Associated with Seizures and Epilepsy.

Authors:  Melissa Barker-Haliski; H Steve White
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-22       Impact factor: 6.915

Review 5.  Analgesic neuropeptide W suppresses seizures in the brain revealed by rational repositioning and peptide engineering.

Authors:  Brad R Green; Misty Smith; Karen L White; H Steve White; Grzegorz Bulaj
Journal:  ACS Chem Neurosci       Date:  2010-11-18       Impact factor: 4.418

6.  Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2.

Authors:  Cameron S Metcalf; Misty D Smith; Brian D Klein; Daniel R McDougle; Liuyin Zhang; Grzegorz Bulaj
Journal:  Neurochem Res       Date:  2017-04-06       Impact factor: 3.996

7.  GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.

Authors:  Xiaoying Lu; Edward Roberts; Fengcheng Xia; Manuel Sanchez-Alavez; Tianyu Liu; Roger Baldwin; Stephanie Wu; James Chang; Claude G Wasterlain; Tamas Bartfai
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

8.  Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery.

Authors:  Charles R Robertson; Erika Adkins Scholl; Timothy H Pruess; Brad R Green; H Steve White; Grzegorz Bulaj
Journal:  J Med Chem       Date:  2010-02-25       Impact factor: 7.446

9.  Synthesis and applications of polyamine amino acid residues: improving the bioactivity of an analgesic neuropeptide, neurotensin.

Authors:  Liuyin Zhang; Hee-Kyoung Lee; Timothy H Pruess; H Steve White; Grzegorz Bulaj
Journal:  J Med Chem       Date:  2009-03-26       Impact factor: 7.446

10.  Convergent synthetic methodology for the construction of self-adjuvanting lipopeptide vaccines using a novel carbohydrate scaffold.

Authors:  Vincent Fagan; Istvan Toth; Pavla Simerska
Journal:  Beilstein J Org Chem       Date:  2014-07-30       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.